Merchant, Michael L <br/><br/>
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.  [electronic resource] 

 -  Kidney international  Mar 2011 
 - 546-554 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2010.468  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--blood<br/>Cytokines--blood<br/>Erythropoietin--therapeutic use<br/>Female<br/>Fibrinopeptide B--analysis<br/>Humans<br/>Male<br/>Oncostatin M Receptor beta Subunit--blood<br/>Peptide Fragments--blood<br/>Proteins--analysis<br/>Renal Dialysis<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization